K08.1
Conditions
Interventions
Group 1: porcine collagen matrix (Mucograft®)
Sponsors
Zentrum der Zahn-, Mund- und Kieferheilkunde (Carolinum) der Goethe Universität Frankfurt, Zahnärztliches Universitäts-Institut gGmbH, Poliklinik für Zahnärztliche Chirurgie und Implantologie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Patients with an age up to 18 years - Subjects must have voluntarily signed the informed consent form before any study related action - patient with one or more implants with keratinized mucosa <2mm -Patient has been informed of the follow-up visits and is willing to return to the clinical center for these follow-up visits (10-14 days, 6 weeks, 3, 6 and 12 months post surgery)
Exclusion criteria
Exclusion criteria: -Systemic disease that could interfere with dental implant therapy (e.g. uncontrolled diabetes, osteoporosis) -Bone metabolism disorders and intake of medications (bisphosphonate, steroids) -Pregnant or breastfeeding women
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| - To determine surgical time necessary for both grafting procedures. - To evaluate and compare the clinical appearance of the grafted areas after both grafting procedures. - To establish KT width gain after both grafting procedures. | — |
Primary
| Measure | Time frame |
|---|---|
| To assess and compare three-dimensional (3D) changes of porcine collagen matrix (Mucograft®) versus autogenous FGG for keratinized mucosa gain around dental implants over a 12-month follow-up period. | — |
Countries
Germany
Contacts
Public ContactTanja Eisenbach
Zentrum der Zahn-, Mund- und Kieferheilkunde des Klinikums der Johann Wolfgang Goethe-Universität Frankfurt am MainPoliklinik für Zahnärztliche Chirurgie und Implantologie
Outcome results
None listed